Categories LATEST
Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.
Listen to Gilead Sciences‘ earnings call live and check the real-time transcript
Analysts’ consensus estimate for September-quarter earnings is $1.81 per share, on an adjusted basis, which marks a decline from $1.90 per share the company earned in the year-ago quarter. Revenue is expected to be $6.42 billion, up 4.8% year-over-year.
For the second quarter, the company reported total revenue of $6.6 billion, which is up 5% year-over-year. Net income attributable to Gilead was $1 billion or $0.83 per share in Q2, compared to $1.1 billion, or $0.91 per share last year. Adjusted EPS decreased 15% to $1.34.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
IPO News: What to look for when Lumexa Imaging goes public
IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in public listings. The recovery has been supported by lower interest
AutoZone (AZO) Q1 2026 Earnings: Key financials and quarterly highlights
AutoZone, Inc. (NYSE: AZO) reported its first quarter 2026 earnings results today. Net sales were $4.6 billion, up 8.2% from the same period a year ago. Same store sales were up
Earnings Preview: General Mills (GIS) projected to report lower sales and earnings for Q2 2026
Shares of General Mills, Inc. (NYSE: GIS) stayed green on Monday. The stock has dropped 8% over the past three months. The branded foods company is scheduled to report its
